CD40 and metastatic melanoma: CD40, a member of the TNF receptor superfamily, enhances T-cell activity and has shown promise in clinical trials with CD40 agonistic antibodies combined with immune checkpoint inhibitors for treating metastatic melanoma (52, 54, 91, 92).